KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,781 | +17.7% | 7,011 | -4.6% | 0.00% | – |
| Q2 2023 | $103,502 | +25.4% | 7,351 | -4.2% | 0.00% | – |
| Q1 2023 | $82,561 | -7.8% | 7,673 | +28.3% | 0.00% | – |
| Q4 2022 | $89,565 | -18.6% | 5,979 | -30.1% | 0.00% | -100.0% |
| Q3 2022 | $110,000 | +32.5% | 8,549 | 0.0% | 0.00% | – |
| Q2 2022 | $83,000 | +16.9% | 8,549 | +19.3% | 0.00% | – |
| Q1 2022 | $71,000 | -15.5% | 7,164 | 0.0% | 0.00% | – |
| Q4 2021 | $84,000 | +300.0% | 7,164 | +290.0% | 0.00% | – |
| Q3 2021 | $21,000 | -19.2% | 1,837 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -23.5% | 1,837 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | +6.2% | 1,837 | 0.0% | 0.00% | – |
| Q4 2020 | $32,000 | +14.3% | 1,837 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | – | 1,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |